Literature DB >> 168514

Giant axonal neuropathy. A clinical entity affecting the central as well as the peripheral nervous system.

H Igisu, M Ohta, T Tabira, S Hosokawa, I Goto.   

Abstract

An 8-year-old girl had progressive muscle weakness and a unique posture of the lower limbs, areflexia, distal sensory impairment, and remarkably kinky hair. Histologic examination of the sural nerve showed giant axons filled with neurofilamentous masses. The clinical and histologic findings resembled those of recent cases reported as "giant axonal neuropathy." Our patient's precocious puberty, Babinski's sign, and electroencephalographic abnormalities suggested central nervous system involvement. Two cases previously reported and the present one appear to represent a new clinical entity that affects the central and the peripheral nervous system.

Entities:  

Mesh:

Year:  1975        PMID: 168514     DOI: 10.1212/wnl.25.8.717

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

1.  Giant axonal neuropathy: report on a case with focal fiber loss.

Authors:  M Sabatelli; E Bertini; S Servidei; E Fernandez; S Magi; P Tonali
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Spastic paraplegia with neurogenic amyotrophy manifesting ballooned axons in sural nerve.

Authors:  M Shimono; M Ohta; Y Kuroiwa
Journal:  Acta Neuropathol       Date:  1977-07-15       Impact factor: 17.088

Review 3.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

4.  Giant axonal neuropathy. Involvement of peripheral nerve, myenteric plexus and extra-neuronal area.

Authors:  D Gambarelli; J Hassoun; J F Pellissier; M O Livet; N Pinsard; M Toga
Journal:  Acta Neuropathol       Date:  1977-08-31       Impact factor: 17.088

5.  Infantile chronic peripheral neuropathy with giant axons. Report of a case.

Authors:  H Jedrzejowska; H Drac
Journal:  Acta Neuropathol       Date:  1977-03-31       Impact factor: 17.088

6.  Giant axonal neuropathy. Endocrinological and histological studies.

Authors:  A Fois; P Balestri; M A Farnetani; R Berardi; R Mattei; E Laurenzi; C Alessandrini; R Gerli; A Ribuffo; S Calvieri
Journal:  Eur J Pediatr       Date:  1985-09       Impact factor: 3.183

7.  Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation.

Authors:  Saleemulla Mahammad; S N Prasanna Murthy; Alessandro Didonna; Boris Grin; Eitan Israeli; Rodolphe Perrot; Pascale Bomont; Jean-Pierre Julien; Edward Kuczmarski; Puneet Opal; Robert D Goldman
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

8.  Giant axonal neuropathy. A neuropathological study.

Authors:  H A Kretzschmar; B O Berg; R L Davis
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

9.  Giant axonal neuropathy: possibly secondary to vitamin b12 malabsorption.

Authors:  S S Schochet; A L Chesson
Journal:  Acta Neuropathol       Date:  1977-09-26       Impact factor: 17.088

10.  Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1.

Authors:  Florence Dequen; Pascale Bomont; Geneviève Gowing; Don W Cleveland; Jean-Pierre Julien
Journal:  J Neurochem       Date:  2008-07-31       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.